FRUTTERO, Roberta

FRUTTERO, Roberta  

SCIENZA E TECNOLOGIA DEL FARMACO  

Mostra records
Risultati 1 - 20 di 46 (tempo di esecuzione: 0.035 secondi).
Titolo Data di pubblicazione Autore(i) File
A multitarget approach to optimize the safety profile of coxibs: lumiracoxib derivatives with dual cyclooxygenase-2 inhibitor-thromboxane A2 receptor antagonist activity 2013 Malvina Hoxha; Valerie Capra; Carola Buccellati; Angelo Sala; Mohammed Abrar Abdul Gaffar Shaikh; Clara Cena; Roberta Fruttero; Alberto Gasco; G. Enrico Rovati; Massimo Bertinaria
A New Synthetic Approach to Substituted β-Carboline Systems 1999 GIUSEPPE ERMONDI; SONJA VISENTIN; D. BOSCHI; ROBERTA FRUTTERO; ALBERTO GASCO
Amphiphile NO-donor antioxidants as polivalent drugs 2006 MARINI E; LAZZARATO L; CHEGAEV K; FRUTTERO R; GASCO A
Aspects of heterocyclic chemistry in developing new 1,4-dihydropyridine Ca2+-antagonists 2000 SONJA VISENTIN; GIUSEPPE ERMONDI; D. BOSCHI; ROBERTA FRUTTERO; ALBERTO GASCO
Aspects of heterocyclic chemistry in developing new 1,4-dihydropyridines Ca2+-agonists 2000 S.Visentin; G.Ermondi; D.Boschi; R. Fruttero; A. Gasco
Carnosine analogues containing Phenol substructures 2012 Giorgis M.; Bertinaria M.; Rolando B.; Montanaro G.; Fruttero R.; Gasco A.
Different multitarget approaches to manage coxibs associatedcardiovascular risk. Design and synthesis of new lumiracoxibderivatives 2012 M. Bertinaria; M. A. A. G. Shaikh; C. Cena; B. Rolando; L. Lazzarato; R. Fruttero; A. Gasco; G. E. Rovati; C. Buccellati; V. Capra; A. Sala
Evaluation of the targeting ability of folate containing liposomal nitrooxy-doxorubicin. 2015 Pedrini, I.; Costamagna, F.; Buondonno, I.; Salaroglio, I. C.; Rolando, B.; Chegaev, K.; Fruttero, R.; Riganti, C.; Arpicco, S.
Hybrid praziquantel-oxadiazole oxides with activity against Schistosoma mansoni. 2011 Daniela Cortese; Francesca Vottero; Stefano Guglielmo; Roberta Fruttero; Alberto Gasco; Latasha Day and David L. Williams.
INCAPSULATED NO-GEMCITABINE: GASEOUS SOLUTION FOR MDR PANCREATIC CANCER 2019 Chegaev, K.; Masetto, F.; Gazzano, E.; Mullappily, N.; Rolando, B.; Donadelli, M.; Arpicco, S.; Riganti, C.; Fruttero, R.
Mechanism governing the partitioning of neutral and cationic forms of (p-methylbenzyl)(alkyl)amines in biomimetic media as revealed by lipophilicity and NMR studies 1997 ROBERTA FRUTTERO; ELISA FORNATTO; D. BOSCHI; GIUSEPPE ERMONDI; ALBERTO GASCO; GIULIA CARON; PIERRE-ALAIN CARRUPT; BERNARD TESTA
MODIFIED DOXORUBICINS: "GASEOUS APPROACH" TO OVERCOME CARDIOTOXICITY AND MULTIDRUG RESISTANCE 2016 Chegaev, K.; Rolando, B.; Gazzano, E.; Riganti, C.; Fruttero, R.
Monitoring patients with fragilities in the context of de-hospitalization services: An Ambient Assisted Living Healthcare Framework for e-Health applications 2019 Emilio Sulis, Ilaria Angela Amantea, Guido Boella, Clara Cena, Roberta Fruttero, Sara Traina, Pierluigi de Cosmo, Lucrezia Armando, Renata Marinello, Dario Bianca, Enrico Brunetti, Mario Bo, Alessandra Bianco, Francesco Cattel, Luca Carlo Feletti, Serena Ambrosini
Multitarget Drugs: No-Donor Doxorubicins 2015 Chegaev, Konstantin; Riganti, Chiara; Gazzano, Elena; Rolando, Barbara; Fruttero, Roberta; Gasco, Alberto
Multitarget drugs: NO-donor doxorubicins 2012 Chegaev K.; Riganti C.; Rolando B.; Federico A.; Fruttero R.; Gasco A.
New class of NO-donor soluble aspirins 2012 Marini E.; Rolando B.; Lazzarato L.; Joseph S.; Fruttero R.
NEW CLASS OF NO-DONORS WITH BONE SELECTIVITY 2003 L. LAZZARATO; LOLLI M.L; BALBO S; DELEIDE G; FRUTTERO R
New furoxan derivatives with Schistosomicidal activity. 2014 Daniela Cortese; David L. Williams; Peter D. Ziniel; Latasha Day; Stefano Guglielmo; Roberta Fruttero; Alberto Gasco.
New NO-donor Bisphosphonates 2001 L. LAZZARATO; LOLLI M.L; DI STILO A; FRUTTERO R; GASCO A
New potent and selective P-gp inhibitors 2013 Guglielmo S.; Bonomo S.; Colabufo N. A.; Contino M.; Perrone M. G.; Fruttero R.; Gasco A.